Considerable Scale-Up Needed to Achieve 2025 Goals for HIV PrEP

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 2, 2024 -- Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Megan E. Peck, Ph.D., from the CDC in Atlanta, and colleagues examined progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) goal of 21.2 million persons using PrEP globally in 2025.

The researchers note that CDC supported 856,816 PrEP initiations in 2023, representing nearly one-quarter of the 3.5 million persons globally who used PrEP that year. During 2017 to 2023, CDC supported PrEP initiations for 2,278,743 persons, who were almost all in sub-Saharan Africa (96.0 percent). Overall, 64.0 percent were female and 44.9 percent were aged 15 to 24 years. For the seven-year period, the CDC achieved 118.7 percent of its PrEP initiation targets. The majority of those initiating PrEP in sub-Saharan Africa were female sex workers, while most in Southeast Asia, Eurasia, and the Americas were men who have sex with men.

"Given the UNAIDS estimate of 3.5 million persons using PrEP globally during 2023, substantial scale-up is needed to reach the 2025 target of 21.2 million persons to reach 2030 goals for ending HIV as a public health threat," the authors write. "Further expansion of PrEP programs that addresses barriers to initiation, including stigma, lack of awareness of PrEP services, and low risk perception among populations at high risk, could increase the number of persons initiating or continuing PrEP."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-03 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords